Creon 19000 [USP'U]/1

Creon 19000 is a prescription medication containing pancrelipase, an enzyme replacement therapy. It is used to treat people who cannot digest food normally due to conditions such as cystic fibrosis, pancreatitis, or pancreatic surgery. The medication works by replacing the enzymes normally produced by the pancreas, allowing for proper digestion and absorption of nutrients. Creon 19000 is available in a delayed-release capsule form.

Creon 19000 is used to treat exocrine pancreatic insufficiency (EPI), a condition where the pancreas does not produce enough digestive enzymes. This can lead to malnutrition and weight loss due to poor digestion and absorption of nutrients. The medication is commonly used in patients with cystic fibrosis, chronic pancreatitis, and those who have undergone pancreatic surgery.

Common side effects of Creon 19000 include abdominal pain, diarrhea, and nausea. In some cases, patients may experience allergic reactions, such as hives, itching, or difficulty breathing. High doses of pancrelipase can also cause hyperuricosuria, a condition characterized by elevated uric acid levels in the urine.

Creon 19000 should be stored at room temperature, away from moisture and heat. The capsules should not be crushed or chewed, as this can cause the enzymes to become inactive. Patients should swallow the capsules whole with a full glass of water, and should not take the medication with antacids or other medications that may interfere with its absorption.

Creon 19000 may interact with other medications, such as antacids, blood thinners, and diabetes medications. Patients should inform their doctor about all medications they are taking before starting treatment with Creon 19000. Additionally, patients with gout or kidney disease should use the medication with caution, as it may exacerbate these conditions.